Endogenous NO-release Carbon Nanodots for Tumor-specific Gas Therapy

Author(s):  
Xue Liu ◽  
Yulin Liu ◽  
Avnesh S. Thakor ◽  
Bhavesh D. Kevadiya ◽  
Jiamin Cheng ◽  
...  
Keyword(s):  
2005 ◽  
Vol 9 (3) ◽  
pp. 337-337 ◽  
Author(s):  
Messoud Ashina ◽  
Marianne Jorgensen ◽  
Bente Stallknecht ◽  
Hanne Mork ◽  
Lars Bendtsen ◽  
...  
Keyword(s):  

Chemosensors ◽  
2021 ◽  
Vol 9 (3) ◽  
pp. 52
Author(s):  
Nermine V. Fares ◽  
Passant M. Medhat ◽  
Christine M. El Maraghy ◽  
Sherif Okeil ◽  
Miriam F. Ayad

Two inexpensive and simple methods for synthesis of carbon nanodots were applied and compared to each other, namely a hydrothermal and microwave-assisted method. The synthesized carbon nanodots were characterized using transmission electron microscopy (TEM), ultraviolet-visible (UV-Vis), photoluminescence (PL), Fourier transform-infrared spectroscopy (FTIR), and X-ray diffraction (XRD). The synthesized microwave carbon nanodots had smaller particle size and were thus chosen for better electrochemical performance. Therefore, they were used for our modification process. The proposed electrodes performance characteristics were evaluated according to the IUPAC guidelines, showing linear response in the concentration range 10−6–10−2, 10−7–10−2, and 10−8–10−2 M of tobramycin with a Nernstian slope of 52.60, 58.34, and 57.32 mV/decade for the bare, silver nanoparticle and carbon nanodots modified carbon paste electrodes, respectively. This developed potentiometric method was used for quantification of tobramycin in its co-formulated dosage form and spiked human plasma with good recovery percentages and without interference of the co-formulated drug loteprednol etabonate and excipients.


2021 ◽  
Vol 68 (3) ◽  
pp. 1101-1106
Author(s):  
Yong Fang ◽  
Zhiwei Zhao ◽  
Mengru Zhu ◽  
Zhengjin Weng ◽  
Chao Fang ◽  
...  

Nano Research ◽  
2021 ◽  
Author(s):  
Yu Gao ◽  
Wenzhan Xu ◽  
Fang He ◽  
Pengbo Nie ◽  
Qingdan Yang ◽  
...  

2021 ◽  
pp. 107815522110306
Author(s):  
Galit Levin ◽  
Paul JM Sessink

Purpose The purpose of this study was to test the efficacy of ChemfortTM, an air filtration closed-system drug transfer device to prevent release of chemotherapy drug vapors and aerosols under extreme conditions. The air cleaning system is based on the adsorption of drug vapors by an activated carbon filter in the Vial Adaptor before the air is released out of the drug vial. The functionality of the carbon filter was also tested at the end of device’s shelf life, and after a contact period with drug vapors for 7 days. Cyclophosphamide and 5-fluorouracil were the chemotherapy drugs tested. Methods The Vial Adaptor was attached to a drug vial and both were placed in a glass vessel. A needle was punctured through the vessel stopper and the Vial Adaptor septum to allow nitrogen gas to flow into the vial and to exit the vial via the air filter into the glass vessel which was connected to a cold trap. Potential contaminated surfaces in the trap system were wiped or rinsed to collect the escaped drug. Samples were analyzed using liquid chromatography tandem mass spectrometry. Results Cyclophosphamide and 5-fluorouracil were detected on most surfaces inside the trap system for all Vial Adaptors without an activated carbon filter. Contamination did not differ between the Vial Adaptors with and without membrane filter indicating no effect of the membrane filter. The results show no release of either drug for the Vial Adaptors with an activated carbon filter even after 3 years of simulated aging and 7 days of exposure to drug vapors. Conclusions Validation of air cleaning CSTDs is important to secure vapor and aerosol containment of chemotherapy and other hazardous drugs. The presented test method has proven to be appropriate for the validation of ChemfortTM Vial Adaptors. No release of cyclophosphamide and 5- fluorouracil was found even for Vial Adaptors after 3 years of simulated aging and 7 days of exposure to drug vapors.


Sign in / Sign up

Export Citation Format

Share Document